Philip Morris Rumored to Make $20mm Investment in Cannabis Device Manufacturer

syqe inhaler

An unconfirmed Reuters report suggests that tobacco giant Philip Morris is investing $20mm into Israeli company Syqe Medical to develop a device aimed at reducing health risks associated with smoking tobacco.  Syqe Medical has developed a novel portable meter-dosed cannabis inhaler that has been studied in a clinical trial, the results of which were published in Journal of Pain & Palliative Care Pharmacotherapy in September 2014.


Read Ari Rabinovitch’s “Philip Morris to invest $20 mln in firm developing inhaler -report”:

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter